The LD cell line (ER−/PR−/HER2+) was successfully established directly from a human breast cancer postsurgery sample (Figure S1), while the SK-BR-3 cell line exhibits ER−/PR−/HER2+. This evidence concerns the gene ERBB2 and breast cancer.